Emerging Perspectives on Polyphenols and Their Role in Food Quality and Human Health

1. Introduction

Polyphenols, a large and heterogeneous family of plant secondary metabolites, have rapidly emerged as focal points in food science, nutrition, and public health research. Once considered niche phytochemicals of limited practical relevance, they are now recognized as central dietary constituents with implications for both food quality and human health. This transition reflects not only advances in analytical techniques that have enabled more precise characterization of polyphenol profiles in foods, but also a growing body of mechanistic and clinical evidence pointing to their multifaceted biological effects.Several factors account for the heightened interest in polyphenols. First, they are widely distributed in plant-based foods and beverages such as fruits, vegetables, tea, coffee, cocoa, nuts, seeds, legumes, herbs, and spices [1]. This ubiquity ensures that polyphenols contribute significantly to total dietary phytochemical intake in most populations, even in the absence of supplementation. Second, polyphenols exhibit multifunctional properties relevant to food science and technology. Their well-documented antioxidant capacity allows them to scavenge free radicals and chelate transition metals, thereby slowing oxidative deterioration in food systems. In addition, they influence color (e.g., anthocyanins in berries and red wine), bitterness, and astringency (e.g., tannins in tea and cocoa), thereby shaping sensory qualities central to consumer acceptance [2]. Many polyphenols also demonstrate antimicrobial and antifungal activities, suggesting potential as natural preservatives and as functional components in edible coatings and active packaging.

Third, an expanding body of epidemiological, clinical, and mechanistic evidence suggests that polyphenols contribute to the prevention and management of chronic diseases. Cardiometabolic conditions such as hypertension, dyslipidemia, and type 2 diabetes have been the most intensively studied, with meta-analyses showing small but significant improvements in blood pressure, lipid profiles, and glycemic control following polyphenol-rich interventions. Evidence is also accumulating for neurocognitive benefits, reduced systemic inflammation, and potential contributions to musculoskeletal health and gut barrier integrity. Importantly, many of these effects appear to be mediated not by the native polyphenols themselves, which are often poorly bioavailable, but by their metabolites generated through gut microbiota-driven transformations [3]. This highlights the emerging view of the microbiome as a crucial gatekeeper in translating dietary polyphenol intake into systemic health effects.

From a food technology perspective, polyphenols present both opportunities and challenges. Their chemical diversity and sensitivity to processing conditions mean that industrial applications require careful optimization to retain functional activity without compromising product safety or palatability. Processing steps such as thermal treatment, enzymatic oxidation, or fermentation can degrade certain polyphenols (notably anthocyanins) but may also increase the extractability or bioaccessibility of others. Advances in extraction techniques, including subcritical water extraction, ultrasound- and microwave-assisted extraction, and enzyme-assisted methods, now enable the recovery of polyphenols from primary agricultural sources and from food by-products such as fruit pomace, peels, and seeds [4]. This creates opportunities for sustainable valorization and circular bioeconomy strategies, aligning with global goals of reducing food waste and developing functional ingredients, knowledge gaps and translational barriers remain. Quantifying dietary intake is complicated by variability in polyphenol composition across cultivars, maturity stages, processing methods, and analytical approaches. Biomarkers of exposure and effect remain insufficiently standardized, making it difficult to compare results across studies [5]. Moreover, while evidence suggests synergistic effects when polyphenols are consumed as part of whole dietary patterns, the efficacy and safety of isolated supplements are less clear, scalable technological approaches that retain bioactivity in complex food matrices while meeting regulatory and consumer acceptance standards are still under development.

The present review addresses these issues by integrating advances across food chemistry, nutrition, microbiology, and clinical sciences. We aim to provide a consolidated and practical perspective for researchers, food technologists, and health professionals seeking to harness polyphenols in food systems, dietary sources and intake patterns, extraction and stability under processing, roles in food quality and safety, bioavailability and metabolism, and health effects, this review underscores the potential of polyphenols as both technological tools and health-promoting agents [6]. At the same time, we highlight the need for rigorous translational research to ensure that enthusiasm is matched by evidence, thereby paving the way for evidence-based innovation in food and nutrition policy.

2. Chemistry and Classification

Polyphenols represent one of the most diverse groups of plant secondary metabolites, unified by the presence of multiple phenolic hydroxyl groups attached to aromatic rings. Their structural diversity underpins a wide range of physicochemical properties, reactivities, and biological activities [7]. Although over 8,000 polyphenolic structures have been identified in nature, they are conventionally grouped into several major classes based on their core skeletons and substituent patterns.

Flavonoids constitute the largest and most studied class. Characterized by a C6–C3–C6 backbone, they are subdivided into several subclasses including flavonols (e.g., quercetin, kaempferol), flavones (e.g., luteolin, apigenin), flavan-3-ols or catechins (e.g., epicatechin, epigallocatechin gallate), flavanones (e.g., naringenin, hesperidin), anthocyanins (responsible for red, purple, and blue pigmentation in berries and grapes), and isoflavones (notably abundant in soy). Flavonoids are widely distributed across dietary sources such as tea, cocoa, berries, citrus fruits, legumes, and leafy vegetables.Phenolic acids are another important category, generally divided into two families: hydroxybenzoic acids (e.g., gallic acid, protocatechuic acid) and hydroxycinnamic acids (e.g., caffeic, ferulic, and chlorogenic acids) [8]. They are commonly found in coffee, cereals, apples, pears, and certain vegetables. Their simpler structures make them more readily absorbed and metabolized compared with larger polyphenols.

Stilbenes, though less abundant in the human diet, have attracted considerable attention due to compounds such as resveratrol, predominantly found in grapes, red wine, and peanuts. Stilbenes typically exhibit potent antioxidant and signaling properties but occur at relatively low concentrations in most foods.Lignans are another class of phenolic dimers derived from phenylpropanoid precursors. Rich dietary sources include flaxseed, sesame seeds, whole grains, and legumes. Upon ingestion, lignans are metabolized by the gut microbiota into enterolignans, which may exert estrogenic and other bioactive effects [9].

Tannins are high–molecular weight polyphenols that can be subdivided into hydrolyzable tannins (e.g., gallotannins, ellagitannins) and condensed tannins (proanthocyanidins). These compounds strongly contribute to astringency and bitterness in foods such as tea, wine, pomegranates, and some fruits. Their polymeric nature often limits intestinal absorption, though microbial fermentation in the colon generates bioactive metabolites.Several structural features critically influence the solubility, reactivity, and biological fate of polyphenols. The molecular weight and degree of polymerization largely determine bioaccessibility; monomers and dimers are generally more absorbable than large polymers. Glycosylation patterns affect solubility and transport, with glycosides often requiring hydrolysis by intestinal enzymes or microbiota prior to absorption [10]. The number and position of hydroxyl groups, along with conjugation and methylation, also govern antioxidant capacity and interaction with proteins, lipids, and carbohydrates in food matrices, the chemical diversity of polyphenols underlies both their technological relevance in food systems and their broad spectrum of biological effects in humans. Understanding these structural determinants is therefore essential for predicting functionality, optimizing extraction and processing, and interpreting variability in health outcomes.

3. Dietary Sources and Intake Patterns

Polyphenols are widely distributed across the human diet, with several foods and beverages serving as primary contributors. Among the most significant are tea and coffee, which together account for a substantial proportion of total polyphenol intake in many populations. Tea provides catechins, theaflavins, and flavonols, while coffee is particularly rich in chlorogenic and other hydroxycinnamic acids. Cocoa and chocolate products are another major source, supplying flavan-3-ols and procyanidins, especially in minimally processed forms. Fruits and vegetables contribute diverse classes: berries and grapes provide anthocyanins and flavonols; apples and onions are rich in quercetin derivatives; and citrus fruits supply flavanones such as hesperidin and naringenin. Nuts and seeds (e.g., walnuts, hazelnuts, flaxseed, sesame) add phenolic acids, lignans, and flavonoids, while red wine and other fermented products deliver a mixture of flavonoids and stilbenes such as resveratrol [11]. Finally, a wide range of herbs and spices—including cloves, oregano, rosemary, turmeric, and cinnamon—are concentrated sources of bioactive polyphenols, often consumed in smaller amounts but with high potency.

Intake patterns vary widely according to geography, cultural practices, and dietary traditions. Mediterranean-style diets, rich in fruits, vegetables, whole grains, legumes, olive oil, and moderate red wine, are typically high in polyphenols, reflecting both diversity and complexity of sources. East Asian diets often contribute high amounts of flavan-3-ols and flavonols from tea consumption, while in Western diets coffee and cocoa are among the dominant contributors [12]. Importantly, polyphenols are rarely consumed as isolated compounds; instead, individuals ingest complex mixtures that may act synergistically within the context of whole dietary patterns.

Efforts to quantify polyphenol intake are complicated by heterogeneity in food composition databases, differences in analytical methods, and natural variability in polyphenol content due to cultivar, degree of ripeness, environmental factors, storage, and processing methods, the bioactive fraction ultimately available to the human body depends on bioaccessibility, metabolism, and gut microbial transformations, which are not fully captured by food composition data [13], population-based studies estimate daily intakes ranging from a few hundred milligrams to over one gram, underscoring the importance of polyphenols as a regular component of human diets.

4. Extraction, Stability, and Effects of Food Processing

4.1 Extraction and Valorization

The efficient recovery of polyphenols from raw materials is essential for both research applications and industrial-scale fortification of functional foods. Traditional solvent-based extraction methods, though effective, are increasingly viewed as unsustainable due to their reliance on organic solvents and high energy inputs. Recent advances emphasize the adoption of “green” extraction techniques designed to be environmentally friendly, food-compatible, and capable of preserving sensitive compounds [14].

Subcritical water extraction utilizes pressurized hot water (100–374 °C) to alter solvent polarity, thereby enabling the selective recovery of polyphenols without organic solvents. This method has demonstrated high efficiency for extracting phenolic acids and flavonoids from plant matrices. Similarly, enzyme-assisted extraction leverages cell wall–degrading enzymes (e.g., cellulases, hemicellulases, pectinases) to enhance the release of bound polyphenols, increasing yield and reducing processing time.

Physical methods such as ultrasound-assisted extraction (UAE) and microwave-assisted extraction (MAE) improve mass transfer and cell disruption, significantly reducing extraction times compared with conventional techniques. In many cases, these approaches also enhance the functional properties of extracts by preserving antioxidant activity [15]. Importantly, these technologies can be applied not only to primary plant sources but also to agro-industrial by-products such as fruit pomace, peels, and seeds. Valorizing such side streams aligns with circular economy principles, creating opportunities for upcycling waste into value-added functional ingredients.

4.2 Effects of Food Processing

Polyphenol content and functionality are strongly influenced by processing conditions. While polyphenols are often regarded as sensitive to degradation, evidence suggests that the effects of processing are bidirectional: certain treatments reduce bioactivity, whereas others improve extractability or bioavailability.

Thermal treatments (e.g., pasteurization, baking, sterilization) can degrade heat-labile polyphenols such as anthocyanins and certain flavonoids. Temperature-induced breakdown may reduce antioxidant capacity and alter sensory qualities such as color. Conversely, moderate heating sometimes increases measurable polyphenol levels by disrupting cell walls and releasing bound compounds, particularly phenolic acids.

Enzymatic oxidation and pH shifts also contribute to variability. Anthocyanins, for example, are highly unstable under alkaline conditions, whereas catechins readily undergo oxidative polymerization, altering flavor and functionality. In contrast, fermentation and controlled enzymatic hydrolysis may enhance health-relevant properties by liberating bound polyphenols or converting them into more bioaccessible forms. For instance, fermentation of cocoa beans or tea leaves generates secondary polyphenolic derivatives that contribute both to flavor and to antioxidant properties.

Systematic reviews highlight that different processing techniques exert variable and context-specific effects on polyphenol quantity, chemical form, and subsequent bioavailability. This variability underscores the need for careful optimization of processing parameters—balancing safety, sensory acceptance, and nutritional preservation [16]. From an industrial perspective, designing processing pipelines that retain polyphenol functionality without compromising product stability represents a central challenge for the development of polyphenol-enriched foods.

5. Functional Roles in Food Quality and Safety

Polyphenols contribute to food quality in several interlinked ways, spanning preservation, sensory attributes, and innovative applications in food packaging. Their multifunctionality makes them valuable not only as health-promoting agents but also as natural alternatives to synthetic additives in the food industry.

5.1 Antioxidant Protection

Oxidative degradation of lipids and pigments is a major cause of food quality deterioration, leading to rancidity, color fading, and shortened shelf life. Polyphenols help prevent these processes by scavenging reactive oxygen species (ROS) and chelating transition metals such as iron and copper, which catalyze lipid peroxidation. For example, catechins and rosmarinic acid have demonstrated strong antioxidative effects in meat and dairy products, while phenolic acids from plant extracts can stabilize edible oils. By slowing oxidation, polyphenols extend product shelf life and reduce the need for synthetic antioxidants such as butylated hydroxytoluene (BHT), thereby meeting consumer demand for “clean-label” products.

5.2 Antimicrobial and Antifungal Activity

Polyphenols exert direct antimicrobial effects against a wide range of foodborne pathogens (e.g., Escherichia coli, Salmonella, Listeria monocytogenes) and spoilage organisms (e.g., Aspergillus and Penicillium species). Mechanisms of action include disruption of microbial cell membranes, inhibition of key enzymes, and metal ion chelation that destabilizes microbial metabolism. Such effects position polyphenols as promising natural preservatives.

Recent studies have explored their application in edible coatings and beverages, demonstrating that incorporation of phenolic-rich extracts (e.g., from grape seeds or green tea) can significantly delay microbial growth during storage. Polyphenol-rich coatings not only extend shelf life but also improve food safety, providing a dual benefit that aligns with industry priorities.

5.3 Sensory Attributes: Color, Bitterness, and Astringency

Polyphenols strongly influence the sensory profile of foods and beverages. Anthocyanins are key determinants of vibrant colors in berries, red wine, and juices, contributing to consumer appeal but also presenting challenges due to their instability during processing and storage. Tannins, meanwhile, impart astringency and bitterness through interactions with salivary proteins. While these traits are desirable in certain products such as wine, tea, and dark chocolate, excessive concentrations can reduce consumer acceptance.Thus, food technologists must carefully balance polyphenol levels to optimize both functional benefits and palatability. Approaches include selective extraction, enzymatic modification, or blending with complementary flavor compounds to achieve a desirable sensory profile while retaining bioactivity.

5.4 Active and Intelligent Packaging

A particularly innovative application involves integrating polyphenols into active and intelligent packaging systems. Polyphenol-rich extracts have been incorporated into edible films and coatings based on biopolymers such as chitosan, alginate, and starch. These films exhibit antioxidant and antimicrobial activity, creating a protective barrier that slows food spoilage.

Beyond passive protection, “intelligent” systems are under development that allow controlled release of polyphenols in response to environmental triggers such as humidity, temperature, or microbial activity. For example, polyphenol–chitosan films can release bioactive compounds when moisture levels rise, actively countering microbial growth in perishable foods. Such approaches hold promise for commercial translation, aligning with sustainability goals by reducing food waste and reliance on synthetic preservatives.

6. Bioavailability, Metabolism, and the Gut Microbiota

6.1 Low Parent-Compound Bioavailability — The Microbiome as a Gatekeeper

One of the defining features of dietary polyphenols is their generally low bioavailability in native form. Most polyphenols are consumed as glycosides, esters, or polymeric structures such as tannins and proanthocyanidins, which are poorly absorbed in the small intestine due to their size, polarity, and chemical complexity. As a result, a large fraction of ingested polyphenols escapes absorption in the upper gastrointestinal tract and reaches the colon largely intact.

Within the colon, the gut microbiota plays a pivotal role as a metabolic gatekeeper. Microbial enzymes such as glycosidases, esterases, and reductases cleave glycosidic bonds, hydrolyze esters, and depolymerize complex structures into smaller, more absorbable metabolites. For example, microbial degradation of flavonoids and lignans yields various phenolic acids, while ellagitannins are converted into urolithins. These metabolites often display enhanced bioavailability and may be the true mediators of systemic health effects, rather than the parent compounds themselves.

Importantly, interindividual variability in microbiota composition contributes to significant differences in metabolic profiles and biological responses to polyphenol-rich diets. For instance, only certain individuals (so-called “urolithin producers”) can generate urolithins from ellagitannins, which may partly explain inconsistencies in clinical outcomes across studies. This highlights the need for personalized nutrition approaches that consider microbiome-mediated differences in polyphenol metabolism.

6.2 Food Matrix and Co-Ingested Nutrients

The food matrix and accompanying nutrients strongly influence polyphenol release, absorption, and subsequent metabolism. Interactions with macronutrients can alter the fate of polyphenols in several ways.

• Dietary fats may enhance solubilization and micellar incorporation of lipophilic polyphenols (e.g., curcumin, resveratrol), thereby improving intestinal absorption.
• Proteins and polysaccharides can form complexes with polyphenols through hydrogen bonding or hydrophobic interactions. While such binding can reduce immediate absorption in the small intestine, it may prolong intestinal residence time or facilitate delivery to the colon, where microbial transformation can generate bioactive metabolites.
• Dietary fiber may entrap polyphenols within its matrix, limiting their release in the upper gut but increasing their availability for colonic fermentation.
• Carbohydrates and sugars can stabilize anthocyanins and other flavonoids in food systems, but excessive sugar intake may also modulate microbial composition in ways that influence polyphenol metabolism indirectly.

Together, these interactions underscore the importance of dietary context: polyphenols rarely act in isolation, and their health effects are best understood within the complexity of whole diets.

6.3 Strategies to Improve Bioavailability

Given the limited absorption of native polyphenols, numerous strategies have been investigated to enhance bioavailability and bioefficacy.

• Nanoemulsions and encapsulation technologies: Lipid-based carriers, liposomes, and nanoemulsions improve solubility and protect polyphenols from degradation in the gastrointestinal tract. For example, encapsulated curcumin demonstrates markedly higher plasma levels compared to unformulated curcumin.
• Microencapsulation for controlled release: Encapsulation in biopolymers such as alginate, chitosan, or starch enables targeted release in the intestine or colon, protecting compounds from gastric degradation.
• Co-administration with bioenhancers: Certain natural compounds, such as piperine, inhibit conjugative metabolism (e.g., glucuronidation), thereby enhancing systemic exposure of polyphenols like curcumin.
• Food matrix engineering: Designing foods to incorporate polyphenols into lipid-rich or protein-stabilized matrices can improve stability and absorption while maintaining sensory quality. Fortified yogurts, beverages, and bakery products enriched with encapsulated polyphenols are increasingly being explored.

Although these approaches are promising, scalability and safety evaluations remain critical barriers to widespread food-industry adoption. Nano- and microencapsulation technologies must be assessed for long-term safety, regulatory compliance, and cost-effectiveness before commercial application. Furthermore, strategies must not compromise sensory attributes, as bitterness or astringency may reduce consumer acceptance.

Recent research emphasizes the development of food-compatible technologies—for example, incorporating polyphenols into dairy matrices, bakery products, or plant-based beverages in ways that enhance bioaccessibility without altering taste or texture. Such innovations hold promise for translating the biochemical potential of polyphenols into practical dietary solutions.

Polyphenol bioavailability is determined by a complex interplay between intrinsic structural features, gut microbial metabolism, dietary context, and technological formulation strategies. The gut microbiota is increasingly recognized as a central mediator, converting poorly absorbed parent compounds into smaller, bioactive metabolites that may account for much of the observed health benefits. At the same time, interactions with food matrices and co-ingested nutrients modulate release and absorption, while novel formulation strategies aim to overcome inherent bioavailability limitations. Future progress will likely require integrating personalized nutrition approaches with scalable food technologies, ensuring that polyphenol bioactivity can be harnessed in ways that are safe, effective, and acceptable to consumers.

7. Health Effects: Evidence from Epidemiology, Clinical Trials, and Mechanistic Studies

Polyphenols have attracted increasing scientific and clinical interest for their potential role in the prevention and management of chronic diseases. The convergence of epidemiological observations, randomized clinical trial (RCT) data, and mechanistic insights provides a multidimensional understanding of their health effects, though notable uncertainties remain. Evidence suggests that polyphenols, especially when consumed as part of whole dietary patterns rather than isolated supplements, may confer modest but clinically relevant benefits across several health domains.

7.1 Cardiometabolic Health

Cardiometabolic disorders, including hypertension, dyslipidemia, obesity, and type 2 diabetes, represent a leading global burden of disease and remain a central target for polyphenol research.

Blood pressure: Multiple meta-analyses of RCTs report small but significant reductions in both systolic and diastolic blood pressure following interventions with catechin-rich green tea, anthocyanins, or curcumin. The magnitude of effect is modest (≈2–5 mmHg) but clinically meaningful, especially in populations at elevated baseline risk.

Lipid profiles: Evidence from RCTs shows that flavonoid-rich foods such as cocoa, berries, and soy isoflavones can reduce total cholesterol and LDL cholesterol. Effects on HDL cholesterol and triglycerides are less consistent, likely due to variations in background diet, baseline metabolic status, and intervention duration.

Glycemic control: Polyphenols have demonstrated modest improvements in fasting glucose, glycated hemoglobin (HbA1c), and insulin sensitivity. Mechanisms include inhibition of carbohydrate-digesting enzymes, attenuation of postprandial glucose excursions, and enhancement of insulin signaling.

At the mechanistic level, cardiometabolic benefits are attributed to endothelial protection, improved nitric oxide bioavailability, reduced oxidative stress, and anti-inflammatory effects. Compared with pharmacological therapies, the effect sizes are smaller, yet polyphenols may contribute as an adjunctive dietary strategy within broader lifestyle interventions.

7.2 Neurocognitive Function and Aging

Cognitive decline and neurodegenerative diseases such as Alzheimer’s disease are major concerns in aging societies.

Epidemiological evidence: Large cohort studies consistently report that higher intake of polyphenol-rich foods (e.g., berries, tea, coffee, cocoa, red wine) is associated with slower cognitive decline and reduced dementia risk.

Clinical trial findings:

• Cocoa flavanols have been shown to improve cerebral blood flow and cognitive performance in older adults, with acute and chronic supplementation yielding benefits in executive function and processing speed.
• Curcumin supplementation has been linked to modest improvements in memory and attention in small RCTs.
• Anthocyanin-rich berries have been associated with enhanced neuronal signaling and reduced oxidative stress markers.

Mechanisms: Proposed pathways include antioxidant defense, attenuation of neuroinflammation, improved neurovascular coupling, and modulation of synaptic plasticity. Despite promising results, heterogeneity in trial design, duration, and cognitive assessment tools means that evidence remains suggestive rather than conclusive.

7.3 Musculoskeletal Health and Sarcopenia

Aging is accompanied by progressive muscle mass and strength loss (sarcopenia), contributing to frailty and impaired quality of life. Polyphenols are hypothesized to protect against sarcopenia by mitigating chronic inflammation, oxidative stress, and mitochondrial dysfunction.

Intervention studies:

• Green tea catechins combined with exercise have improved muscle strength and endurance in some studies of older adults.
• Isoflavones and resveratrol have shown potential to attenuate bone resorption and support lean body mass.

Systematic reviews: The evidence is heterogeneous and often limited by small sample sizes, short trial durations, and inconsistent outcome measures. While preliminary findings are encouraging, more robust RCTs are needed to confirm whether polyphenol supplementation can meaningfully reduce sarcopenia risk or enhance musculoskeletal resilience.

7.4 Gut Health, Immunity, and Inflammation

Polyphenols play a pivotal role at the diet–microbiome–immune interface. Acting as substrates for microbial metabolism, they generate bioactive metabolites that influence intestinal and systemic physiology.

Gut barrier function: Polyphenols such as epigallocatechin gallate (EGCG) and quercetin strengthen tight junction integrity and reduce gut permeability in preclinical models.

Immunomodulation and inflammation: Observational and interventional studies show that polyphenol-rich diets can lower circulating inflammatory markers, including C-reactive protein (CRP) and interleukin-6 (IL-6).

Microbiota modulation: Polyphenols promote the growth of beneficial taxa (e.g., Bifidobacterium, Lactobacillus) while suppressing potentially pathogenic bacteria, suggesting prebiotic-like effects.

Taken together, polyphenols may exert systemic benefits via immune regulation and inflammation control, though large-scale human trials are still relatively scarce.

7.5 Cancer and Other Endpoints

Polyphenols have long been studied for their potential anticarcinogenic properties.

Preclinical evidence: In vitro and animal studies consistently demonstrate antiproliferative, pro-apoptotic, anti-angiogenic, and anti-metastatic effects of compounds such as resveratrol, curcumin, and EGCG.

Human studies: Observational data suggest that high intake of polyphenol-rich foods may reduce risk of certain cancers (e.g., colorectal, breast, prostate). However, associations are inconsistent across cancer types and populations, and residual confounding by overall diet and lifestyle remains a concern. Long-term, well-controlled RCTs are limited, and those conducted have not provided definitive protective evidence.

Other health outcomes: Emerging research links polyphenols to benefits in skin protection (e.g., UV-induced damage), liver function, and ocular health. However, these domains remain underexplored and require stronger clinical validation.

8. Safety, Interactions, and Regulatory Considerations

8.1 Safety

Polyphenols derived from whole foods—such as fruits, vegetables, tea, coffee, cocoa, and red wine—are widely regarded as safe when consumed in the context of a balanced diet. These dietary sources typically deliver polyphenols in physiologically relevant doses, embedded within complex food matrices that modulate their absorption and metabolism. Epidemiological studies rarely report adverse effects associated with habitual intake, further reinforcing their general safety at dietary levels.

Concerns arise, however, with the use of isolated, high-dose supplements or concentrated extracts, which can reach levels far exceeding those achievable through normal dietary patterns. At these doses, certain polyphenols may exert pro-oxidant effects, disrupt redox balance, or induce gastrointestinal discomfort [7]. For instance, excessive consumption of green tea catechin supplements has been associated with hepatotoxicity in some case reports, prompting safety advisories in specific jurisdictions. Similarly, long-term safety data on chronic supplementation with curcumin, resveratrol, or anthocyanin concentrates remain limited, particularly in vulnerable populations such as children, pregnant women, or individuals with pre-existing liver or kidney disease, while polyphenols are considered safe within food-based exposures, prudence is warranted for pharmacological-level supplementation, and systematic long-term studies are needed to establish safe upper intake thresholds.

8.2 Interactions with Medications and Nutrients

A more complex safety consideration lies in the potential for interactions between polyphenols and medications. Many polyphenols are substrates, inhibitors, or inducers of drug-metabolizing enzymes and transporters, particularly members of the cytochrome P450 (CYP) family, UDP-glucuronosyltransferases (UGTs), and efflux pumps such as P-glycoprotein.

For example:

• Resveratrol and quercetin can inhibit CYP3A4, potentially altering the metabolism of statins, calcium channel blockers, or immunosuppressants.
• Green tea catechins may interfere with the absorption of certain β-blockers and reduce the bioavailability of iron when consumed in large amounts.
• Isoflavones can modulate estrogen receptor activity, raising concerns about interactions with hormonal therapies.

Such interactions may be especially problematic in patients taking narrow-therapeutic-index drugs, including anticoagulants (e.g., warfarin), antiepileptics, or immunosuppressive agents, where even modest pharmacokinetic changes can impact efficacy or safety [8]. Healthcare providers should therefore inquire about supplement use and advise caution for patients self-administering concentrated polyphenol products, polyphenols can also affect nutrient bioavailability. Their tendency to form complexes with dietary proteins or minerals (e.g., iron, zinc) may reduce absorption under certain conditions, although in mixed diets this effect is usually modest and clinically insignificant.

8.3 Regulatory Considerations

The regulatory landscape for polyphenols is heterogeneous across jurisdictions and reflects the dual positioning of these compounds as both food constituents and bioactive agents.

• In the European Union, polyphenol extracts added to foods or marketed as supplements fall under the Novel Foods Regulation if not historically consumed, requiring safety assessment and authorization by the European Food Safety Authority (EFSA). Health claims, such as those linking polyphenols to cardiovascular or cognitive benefits, must be substantiated with high-quality human data and receive EFSA approval before use on labels.
• In the United States, polyphenol supplements are regulated as dietary supplements under the Dietary Supplement Health and Education Act (DSHEA). Manufacturers are responsible for ensuring safety and proper labeling, but disease risk reduction claims are prohibited without explicit Food and Drug Administration (FDA) authorization. Structure–function claims (e.g., “supports heart health”) are permitted if appropriately qualified.
• In Asia and other regions, regulatory frameworks vary. Japan’s “Foods for Specified Health Uses” (FOSHU) and China’s functional food regulations provide pathways for polyphenol-containing products, but requirements for efficacy and safety data differ.

Globally, a recurring challenge is the gap between marketing claims and clinical evidence. While consumer demand for “natural” functional foods and supplements is rising, regulatory agencies emphasize the need for robust evidence on efficacy, safety, and bioavailability before polyphenol-based products can be promoted with health claims.Polyphenols from conventional diets are safe and potentially beneficial, but the transition from food to supplement form introduces uncertainties. Safety concerns center on high-dose, long-term use, potential pro-oxidant activity, and clinically significant drug–nutrient interactions [9]. Regulatory frameworks provide oversight, but variation across countries complicates product development and consumer understanding.

To ensure safe and effective use, future efforts should focus on:

• Establishing upper intake levels for common supplemental polyphenols.
• Conducting long-term safety trials in diverse populations.
• Developing standardized biomarkers to monitor exposure and interactions.
• Harmonizing international regulations to balance innovation with consumer protection.

9. Translational Applications in Food Innovation

The multifunctional properties of polyphenols make them highly attractive to the food industry, not only as health-promoting compounds but also as functional ingredients with technological value. Translating polyphenol science into practical applications requires attention to issues of stability, sensory quality, regulatory approval, and consumer acceptance. Current innovations can be grouped into three major domains.

9.1 Fortified and Functional Foods

The fortification of foods with polyphenol-rich extracts or concentrates is an active area of product development. Examples include berry concentrates in beverages, tea catechins in ready-to-drink teas, and cocoa flavanols in snack bars or dairy products. Such fortification strategies aim to deliver measurable health benefits beyond basic nutrition, aligning with consumer demand for “clean label” and plant-based functional foods.

Key challenges in formulation include:

• Stability: Polyphenols such as anthocyanins are highly sensitive to heat, light, and pH, often degrading during storage or processing.
• Sensory properties: High concentrations of polyphenols can impart bitterness or astringency that compromise palatability. Masking agents, flavor modulators, or careful selection of food matrices are often required.
• Bioavailability: Simply increasing total polyphenol content does not guarantee efficacy. Strategies such as encapsulation, emulsification, or matrix engineering are being investigated to improve release and absorption.

9.2 Natural Preservatives and Packaging

Polyphenols’ antioxidant and antimicrobial activities provide opportunities to replace or complement synthetic food additives [12]. Extracts from rosemary, grape seeds, green tea, and pomegranate have been tested as natural preservatives in meat, dairy, and bakery products, with encouraging results in reducing lipid oxidation and microbial spoilage, polyphenols are increasingly applied in active packaging systems. Research demonstrates that polyphenol-enriched edible films, coatings, and biopolymer-based packaging can extend shelf life by releasing antioxidant or antimicrobial compounds in a controlled manner. For instance, polyphenol–chitosan composites have shown strong antimicrobial activity while maintaining packaging integrity.

9.3 Upcycling Food Waste

The valorization of food processing by-products as polyphenol sources represents a promising pathway for sustainable food innovation [13]. Fruit peels, seed cakes, pomace, coffee husks, and cereal bran are often rich in polyphenols but historically underutilized. Emerging technologies such as subcritical water extraction or enzyme-assisted processing can efficiently recover these compounds, generating high-value functional ingredients from low-cost waste streams.

This approach contributes to circular economy goals by reducing waste, creating new revenue streams, and supporting environmentally responsible food systems. Case studies include the use of grape pomace extracts in bakery products, apple peel polyphenols in snacks, and olive-mill wastewater recovery for nutraceutical applications.

10. Methodological Challenges and Knowledge Gaps

The rapid advances, polyphenol science faces methodological challenges that limit translation into clear dietary recommendations or scalable technologies. These gaps highlight the need for coordinated efforts across food science, nutrition, microbiome research, and clinical medicine.

10.1 Heterogeneity of Exposures

One of the most significant challenges is the heterogeneity in exposure assessment. Different studies report polyphenol intake as:

• total polyphenol content (often measured via Folin–Ciocalteu assay),
• intake of specific subclasses or compounds, or
• proxy estimates based on food frequency questionnaires.

This variability limits cross-study comparability and complicates meta-analyses. Improved food composition databases with standardized values, along with biomarker-based intake assessment, are urgently needed.

10.2 Bioavailability and Biomarkers

Polyphenols undergo extensive metabolism and transformation, making circulating parent compounds poor indicators of intake. Bioavailability is further influenced by the food matrix, co-ingested nutrients, and gut microbiota activity [14]. Currently, there is a lack of reliable, validated biomarkers that reflect both exposure and biological effect. Advances in metabolomics and systems biology may help identify panels of phenolic metabolites that better capture functional exposure.

10.3 Interindividual Variability

Responses to polyphenol intake vary widely among individuals due to genetic polymorphisms, microbiome composition, age, sex, and health status. For example, differences in microbial capacity to metabolize ellagitannins into urolithins strongly influence cardiometabolic outcomes. Such variability complicates interpretation of trial results and highlights the potential for personalized nutrition approaches [15]. Integrating microbiome sequencing and metabolomic profiling into intervention studies may help unravel these differences.

10.4 Standardized Clinical Trials

Although thousands of polyphenol-related trials exist, many are limited by small sample sizes, short duration, inadequate blinding, and poorly characterized interventions. Few large-scale, long-term RCTs have tested polyphenol-rich foods or extracts using clinically relevant endpoints. Standardization in dose selection, formulation, and biomarker outcomes is essential to generate evidence strong enough to support regulatory health claims and clinical practice guidelines.

10.5 Scale-Up and Cost of Food Applications

Industrial translation of polyphenol research requires economically viable extraction and formulation technologies. While green extraction methods (e.g., subcritical water, enzyme-assisted, ultrasound, microwave) show promise, many remain confined to pilot-scale demonstrations. Achieving reproducibility, cost-efficiency, and regulatory approval at scale remains a significant barrier. Furthermore, ensuring that functional activity is preserved during processing and storage is critical for maintaining product efficacy, polyphenols hold tremendous promise as functional ingredients, natural preservatives, and health-promoting dietary components, yet translational progress is constrained by methodological gaps and regulatory hurdles [18]. The heterogeneity in exposure assessment, developing robust biomarkers, accounting for interindividual variability, and conducting standardized, long-term clinical trials will be critical. From an industry perspective, overcoming scale-up, cost, and standardization challenges will determine whether polyphenol-based innovations transition from niche products to mainstream solutions, the interface of food science, systems biology, and personalized nutrition is likely to accelerate progress, ultimately enabling safer, evidence-based integration of polyphenols into both public health strategies and food innovation pipelines.

11. Conclusions

Polyphenols occupy a unique intersection between nutrition science, food technology, and public health. Over the last decade, they have evolved from being studied as isolated phytochemicals to being recognized as multifunctional agents influencing food quality, preservation, and human physiology. Evidence from epidemiology, clinical trials, and mechanistic studies indicates that polyphenol-rich diets can modestly improve cardiometabolic outcomes, support cognitive health, and contribute to healthier aging trajectories. Importantly, these benefits are not mediated by parent compounds alone but rely heavily on gut microbiota transformations, which generate smaller, bioactive metabolites with systemic effects, polyphenols also serve as natural antioxidants, antimicrobials, and color modulators, making them valuable alternatives to synthetic additives in food preservation and packaging. Innovations in green extraction, upcycling of by-products, and integration into active packaging highlight the growing role of polyphenols in sustainable food systems. However, challenges remain in ensuring stability during processing, maintaining sensory acceptability, and achieving scalable, cost-effective applications, the full realization of polyphenols’ potential requires bridging basic mechanistic science with translational food innovation. This includes developing reliable biomarkers of intake and effect, designing large-scale and long-duration human trials, and creating industrially viable formulations that preserve bioactivity without compromising taste or safety. Interdisciplinary collaboration—spanning food chemistry, microbiology, clinical nutrition, and regulatory science—will be essential. With such integration, polyphenols can move beyond niche interest to become cornerstones of healthier, more sustainable food systems

References

• Cory, H., Passarelli, S., Szeto, J., Tamez, M., &Mattei, J. (2018). The role of polyphenols in human health and food systems: A mini-review. Frontiers in nutrition, 5, 370438.
• Tomas-Barberan, F. A., & Andres-Lacueva, C. (2012). Polyphenols and health: current state and progress. Journal of agricultural and food chemistry, 60
• Ray, S. K., & Mukherjee, S. (2021). Evolving interplay between dietary polyphenols and gut microbiota—an emerging importance in healthcare. Frontiers in Nutrition, 8, 634944.
• Cirillo, Giuseppe, Manuela Curcio, Orazio Vittorio, Francesca Iemma, Donatella Restuccia, Umile Gianfranco Spizzirri, Francesco Puoci, and NevioPicci. “Polyphenol conjugates and human health: a perspective review.” Critical Reviews in Food Science and Nutrition 56, no. 2 (2016): 326-337.
• Rathod, N. B., Elabed, N., Punia, S., Ozogul, F., Kim, S. K., & Rocha, J. M. (2023). Recent developments in polyphenol applications on human health: a review with current knowledge. Plants, 12(6), 1217.
• Di Lorenzo, C., Colombo, F., Biella, S., Stockley, C., & Restani, P. (2021). Polyphenols and human health: The role of bioavailability. Nutrients, 13(1), 273.
• Tresserra-Rimbau, A., Lamuela-Raventos, R. M., & Moreno, J. J. (2018). Polyphenols, food and pharma. Current knowledge and directions for future research. Biochemical pharmacology, 156, 186-195.
• Rudrapal, Mithun, Shubham J. Khairnar, Johra Khan, Abdulaziz Bin Dukhyil, Mohammad Azam Ansari, Mohammad N. Alomary, Fahad M. Alshabrmi, SantwanaPalai, Prashanta Kumar Deb, and Rajlakshmi Devi. “Dietary polyphenols and their role in oxidative stress-induced human diseases: Insights into protective effects, antioxidant potentials and mechanism (s) of action.” Frontiers in pharmacology 13 (2022): 806470.
• Ofosu, F. K., Daliri, E. B. M., Elahi, F., Chelliah, R., Lee, B. H., & Oh, D. H. (2020). New insights on the use of polyphenols as natural preservatives and their emerging safety concerns. Frontiers in Sustainable Food Systems, 4, 525810.
• Xiao, J. B., &Hogger, P. (2015). Dietary polyphenols and type 2 diabetes: current insights and future perspectives. Current medicinal chemistry, 22(1), 23-38.
• Câmara, José S., Bianca R. Albuquerque, Joselin Aguiar, Rúbia CG Corrêa, João L. Gonçalves, Daniel Granato, Jorge AM Pereira, Lillian Barros, and Isabel CFR Ferreira. “Food bioactive compounds and emerging techniques for their extraction: Polyphenols as a case study.” Foods 10, no. 1 (2020): 37.
• Saura-Calixto, F., & Pérez-Jiménez, J. (Eds.). (2018). Non-extractable polyphenols and carotenoids: importance in human nutrition and health. Royal Society of Chemistry.
• Garcia-Munoz, C., & Vaillant, F. (2014). Metabolic fate of ellagitannins: implications for health, and research perspectives for innovative functional foods. Critical reviews in food science and nutrition, 54(12), 1584-1598.
• Ruskovska, T., Maksimova, V., &Milenkovic, D. (2020). Polyphenols in human nutrition: from the in vitro antioxidant capacity to the beneficial effects on cardiometabolic health and related inter-individual variability–an overview and perspective. British Journal of Nutrition, 123(3), 241-254.
• Wan, C., Langyan, S., Echeverría, J., Devkota, H. P., Tewari, D., Moosavi, M. A., & Li, M. (2025). Edible fruits and berries as a source of functional polyphenols: Current scene and future perspectives. Phytochemistry Reviews, 24(2), 1197-1225.
• Pop, OanaLelia, Ramona Suharoschi, Sonia AncuțaSocaci, Elaine Berger Ceresino, Achim Weber, Carmen Gruber-Traub, Dan Cristian Vodnar, Anca Corina Fărcaș, and Eva Johansson. “Polyphenols—ensured accessibility from food to the human metabolism by chemical and biotechnological treatments.” Antioxidants 12, no. 4 (2023): 865.
• Del Rio, D., Rodriguez-Mateos, A., Spencer, J. P., Tognolini, M., Borges, G., & Crozier, A. (2013). Dietary (poly) phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxidants & redox signaling, 18(14), 1818-1892.
• Kumar Singh, Amit, Célia Cabral, Ramesh Kumar, RishaGanguly, Harvesh Kumar Rana, Ashutosh Gupta, Maria Rosaria Lauro, Claudia Carbone, Flávio Reis, and Abhay K. Pandey. “Beneficial effects of dietary polyphenols on gut microbiota and strategies to improve delivery efficiency.” Nutrients 11, no. 9 (2019): 2216.